-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
FY2022 EPS Estimates for Avivagen Inc. Decreased by Zacks Small Cap (OTCMKTS:VIVXF)
FY2022 EPS Estimates for Avivagen Inc. Decreased by Zacks Small Cap (OTCMKTS:VIVXF)
Avivagen Inc. (OTCMKTS:VIVXF – Get Rating) – Investment analysts at Zacks Small Cap reduced their FY2022 EPS estimates for shares of Avivagen in a note issued to investors on Wednesday, August 31st. Zacks Small Cap analyst D. Bautz now anticipates that the company will earn ($0.08) per share for the year, down from their prior estimate of ($0.07). The consensus estimate for Avivagen's current full-year earnings is ($0.07) per share.
Get Avivagen alerts:Avivagen (OTCMKTS:VIVXF – Get Rating) last announced its quarterly earnings results on Wednesday, June 15th. The company reported ($0.02) EPS for the quarter, meeting analysts' consensus estimates of ($0.02). The company had revenue of $0.07 million during the quarter, compared to analyst estimates of $0.23 million.
Avivagen Price Performance
Shares of OTCMKTS:VIVXF opened at $0.13 on Friday. The company's 50 day moving average price is $0.14 and its two-hundred day moving average price is $0.15. Avivagen has a 12-month low of $0.12 and a 12-month high of $0.38. The firm has a market cap of $9.33 million, a PE ratio of -1.40 and a beta of 0.13.About Avivagen
(Get Rating)
Avivagen Inc, a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr.
See Also
- Get a free copy of the StockNews.com research report on Avivagen (VIVXF)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.
Avivagen Inc. (OTCMKTS:VIVXF – Get Rating) – Investment analysts at Zacks Small Cap reduced their FY2022 EPS estimates for shares of Avivagen in a note issued to investors on Wednesday, August 31st. Zacks Small Cap analyst D. Bautz now anticipates that the company will earn ($0.08) per share for the year, down from their prior estimate of ($0.07). The consensus estimate for Avivagen's current full-year earnings is ($0.07) per share.
Avivagen Inc.(OTCMKTS：VIVXF-GET Rating)-Zack Small Cap的投資分析師在8月31日星期三發給投資者的一份報告中下調了對Avivagen股票的2022財年每股收益預期。扎克斯小盤分析師D.Bautz現在預計，該公司今年的每股收益將為0.08美元，低於此前預測的0.07美元。對英傑華目前全年收益的普遍預期為每股0.07美元。
Avivagen (OTCMKTS:VIVXF – Get Rating) last announced its quarterly earnings results on Wednesday, June 15th. The company reported ($0.02) EPS for the quarter, meeting analysts' consensus estimates of ($0.02). The company had revenue of $0.07 million during the quarter, compared to analyst estimates of $0.23 million.
Avivagen(OTCMKTS：VIVXF-GET Rating)上一次公佈季度收益是在6月15日星期三。該公司公佈該季度每股收益為0.02美元，符合分析師一致預期的0.02美元。該公司本季度營收為70萬美元，而分析師預期為23萬美元。
Avivagen Price Performance
Avivagen性價比
About Avivagen
關於英傑華
(Get Rating)
(獲取評級)
Avivagen Inc, a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr.
Avivagen Inc是一家生命科學公司，專注於開發家畜飼料產品並將其商業化，這些產品支持免疫功能，幫助動物實現生長和生產力。該公司提供OXC-beta牲畜，這是一種預混料，用於牲畜飼料；
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Avivagen (VIVXF)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
- 免費獲取StockNews.com關於Avivagen的研究報告(VIVXF)
- 隨着管理層重組，股市能否迅速反彈？
- MarketBeat：回顧中的一週8/29-9/2
- 霍梅爾在這些水平上看起來很便宜
- 露露檸檬將飆升至9月
- 耐克股票會被超賣，但仍被高估嗎？
Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.
接受Avivagen Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Avivagen和相關公司的最新新聞和分析師評級的每日簡明摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧